From the globular to the fibrous state: Protein structure and structural conversion in amyloid formation

Quarterly Reviews of Biophysics

Volumn 31, Issue 1, 1998, Pages 1-39

  Sunde, Margaret ^a   Blake, Colin C F ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CALCITONIN; IMMUNOGLOBULIN LIGHT CHAIN; POLYPEPTIDE; PREALBUMIN; PRION PROTEIN;

BIOLOGICAL MODEL; BIOPHYSICS; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; CRYSTAL STRUCTURE; ELECTRON MICROSCOPY; INFRARED SPECTROSCOPY; LYSOSOME; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; STAINING; SYNCHROTRON; VITREOUS BODY; X RAY DIFFRACTION;

AMYLOID; HUMANS; MODELS, MOLECULAR; MURAMIDASE; PREALBUMIN; PROTEIN CONFORMATION;

EID: 0031825554     PISSN: 00335835     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033583598003400     Document Type: Review

References (115)

1. ADAMS, M. J., BLUNDELL, T. L., DODSON, E. J., DODSON, G. G., VIJAYAN, M., BAKER, E. N., HARDING, M. M., HODGKIN, D. C., RIMMER, B. & SHEAT, S. (1969). The structure of rhombohedral 2 zinc insulin crystals. Nature 224, 491-495.
2. ARNOTT, S., DOVER, S. & ELLIOT, A. (1967). Structure of β-poly-L-alanine: refined atomic co-ordinates for an antiparallel beta-pleated sheet. J. molec. Biol. 30, 201-208.
3. ARTYMIUK, P. J. & BLAKE, C. C. F. (1981). Refinement of human lysozyme at 1.5 Å resolution: analysis of non-bonded and hydrogen-bond interactions. J. molec. Biol. 152, 737-762.
4. BARROW, C. J., YASUDA, A., KENNY, P. T. M. & ZAGORSKI, M. G. (1992). Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. J. molec. Biol. 225, 1075-1093.
5. 2-microglobulin. Proc. natn. Acad. Sci. USA 82, 4225-4229.
6. BENSON, M. D. & WALLACE, M. R. (1989). Amyloidosis. In The Metabolic Basis of Inherited Disease (ed. C. P. Scriver, A. L. Beaudet, W. S. Sly and D. Valles), pp. 2439-2460. New York: McGraw-Hill.
7. BESSEN, R. A., KOCISKO, D. A., RAYMOND, G. J., NANDAN, S., LANSBURY, P. T. & CAUGHEY, B. (1995). Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375, 698-700.
8. BLAKE, C. C. F. & OATLEY, S. J. (1977). Protein-DNA and protein-hormone interactions in prealbumin. Nature 268, 115-120.
9. BLAKE, C. C. F. & SERPELL, L. C. (1996). Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix. Structure 4, 989-998.
10. BLAKE, C. C. F., KOENIG, D. F., MAIR, G. A., NORTH, A. C. T., PHILLIPS, D. C. & SARMA, V. R. (1965). Structure of hen egg-white lysozyme. A three dimensional Fourier synthesis at 2 Å resolution. Nature 206, 757-761.
11. BLAKE, C. C. F., GEISOW, M. J., OATLEY, S. J., RERAT, B. & RERAT, C. (1978). Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J. molec. Biol. 121, 339-356.
12. BLAKE, C. C. F., SERPELL, L. C., SUNDE, M. & LUNDGREN, E. (1996). A molecular model of the amyloid fibril. In CIBA Symposium No. 199 The Nature and Origin of Amyloid Fibrils, pp. 6-21. Chichester, U. K.: John Wiley & Sons Ltd.
13. BODE, W., ENGH, R., MUSIL, D., THIELE, U., HUBER, R., KARSHIKOV, A., BRZIN, J., KOS, J. & TURK, V. (1988). The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 7, 2593-2599.
14. BONAR, L., COHEN, A. S. & SKINNER, M. (1969). Characterization of the amyloid fibril as a cross-β protein. Proc. Soc. exp. biol. Med. 131, 1373-1375.
15. BOOTH, D. R., SUNDE, M., BELLOTTI, V., ROBINSON, C. V., HUTCHINSON, W. L., FRASER, P. E., HAWKINS, P. N., DOBSON, C. M., RADFORD, S. E., BLAKE, C. C. F. & PEPYS, M. B. (1997). Instability, unfolding and fibrillogenesis in amyloidogenic lysozyme variants. Nature 385, 787-793.
16. BRADBURY, E. M., BROWN, L., DOWNIE, A. R., ELLIOTT, A., FRASER, R. D. B., HANBY, W. E. & MACDONALD, T. R. R. (1960). The 'cross-beta' structure in polypeptides of low molecular weight. J. molec. Biol. 2, 276-280.
17. BURKE, M. J. & ROUGVIE, M. A. (1972). Cross-β protein structures I. Insulin fibrils. Biochemistry, 11, 2435-2439.
18. BURTNICK, L. D., ROBINSON, R. C. & KOEPF, E. K. (1996). The structure of horse plasma gelsolin to 2.5 Å. Biophys. J. 70, Pt. 2, pSUA12.
19. CAPUTO, C. B., FRASER, P. E., SOBEL, I. E., & KIRSCHNER, D. A. (1992). Amyloid-like properties of a synthetic peptide corresponding to the carboxy-termmus of β-amyloid protein precursor. Arch. Biochem. Biophys. 292, 199-205.
20. CAUGHEY, B. & CHESEBRO, B. (1997) Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol. 7, 56-62.
21. CHOTHIA, C. (1973). Conformations of twisted β-sheets in proteins. J. molec. Biol. 75, 295-302.
22. COHEN, A. S. (1965). The constitution and genesis of amyloid. Int. Rev. exp. Path. 4, 159-243 (ed. G. W. Richter and M. A Epstein), New York: Academic Press.
23. COHEN, A. S. & CALKINS, E. (1959). Electron microscopic observation on a fibrous component in amyloid of diverse origins. Nature 183, 1202-1203.
24. COHEN A. S., SHIRAHAMA, T. & SKINNER, M. (1981). Electron microscopy of amyloid. In Electron Microscopy of Protein, vol. 3, (ed. I. Harriss), pp. 165-205, London: Academic Press.
25. COHEN, F. E., PAN, K.-M., HUANG, Z., BALDWIN, M., FLETTERICK, R. & PRUSINER, S. B. (1994). Structural clues to prion replication. Science 264, 530-531.
26. COLON, W. & KELLY, J. W. (1992). Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31, 8654-8660.
27. COME, J. H., FRASER, P. E. & LANSBURY, P. T. JR. (1993). A kinetic model for amyloid formation in the prion diseases: Importance of seeding. Proc. natn. Acad. Sci. U.S.A. 90, 5959-5963.
28. COOPER, J. H. (1974). Selective amyloid staining as a function of amyloid composition and structure: histochemical analysis of the alkaline Congo red, standardized toluidine blue and iodine methods. Lab. Invest. 31, 232-238.
29. COOPER, J. H. (1976). In Amyloidosis (ed. O. Wehelius and A. Pasternak), pp. 61-68. London, New York: Academic Press.
30. DAMAS, A. M., SEBASTIAO, M. P., DOMINGUES, F. S., COSTA, P. P. & SARAIVA, M. J. (1995). Structural studies on FAP fibrils: removal of contaminants is essential to the interpretation of X-ray data. Amyloid: Int. J. exp. clin. Invest. 2, 173-178.
31. DAMAS, A. M., RIBEIRO, S., LAMZIN, V. S., PALHA, J. A. & SARAIVA, M. J. (1996). Structure of Val122Ile variant transthyretin - a cardiomyopathic mutant. Acta Cryst. D52, 966-972.
32. DE LA PAZ, P., BURRIDGE, J. M., OATLEY, S. J. & BLAKE, C. C. F. (1992). Multiple modes of binding of thyroid hormones and other iodothyronines to human plasma transthyretin. In The Design of Drugs to Macromolecular Targets (ed. Beddell, C. R.), pp. 119-172. John Wiley & Sons Ltd, Chichester, England.
33. EANES, E. D. & GLENNER, G. G. (1968). X-Ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16, 673-677.
34. ENGLANDER, S. W. & MAYNE, L. (1992). Protein folding studied using hydrogen exchange and two dimensional NMR. Ann. Rev. biophys. biomol. Struct. 21, 243-265.
35. ESNOUF, R. M. (1997). An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. molec. Graphics 15, 132.
36. FRASER, P. E., NGUYEN, J. T., SUREWICZ, W. K. & KIRSCHNER, D. A. (1991). pH dependent structural transitions of Alzheimer's amyloid peptides. Biophys. J. 60, 1190-1201.
37. FRASER, P. E., NGUYEN, J. T., INOUYE, H., SUREWICZ, W. K., SELKOE, D. J., PODLISNY, M. B. & KIRSCHNER, D. A. (1992). Fibril formation by primate, rodent, and Dutch-Hemorrhagic analogues of Alzheimer amyloid β-protein. Biochemistry 31, 10716-10723.
38. FRASER, R. B. D. & MACRAE, T. P. (1973). The beta conformation. In Conformations in Fibrous Proteins and Related Synthetic Polypeptides, pp. 218-246. New York: Academic Press.
39. FUNAHASHI, J., TAKANO, K., OGASAHARA, K., YAMAGATA, Y. & YUTANI, K. (1996). The structure, stability, and folding process of amyloidogenic mutant human lysozyme. J. Biochem. 120, 1216-1223.
40. GASSET, M., BALDWIN, M. A., LLOYD, D. H., GABRIEL, J.-M., HOLTZMAN, D. M., COHEN, F. E., FLETTERICK, R. & PRUSINER, S. B. (1992). Predicted α-helical regions of the prion protein, when synthesized as peptides form amyloid. Proc. natn. Acad. Sci. USA 89, 10940-10944.
41. GASSET, M., BALDWIN, M. A., FLETTERICK, R. & PRUSINER, S. B. (1993). Perturbation of secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc. natn. Acad. Sci. USA 90, 1-5.
42. GEDDES, A. J., PARKER, K. D., ATKINS, E. D. T. & BEIGHTON, E. A. J. (1968). 'Cross β' conformation in proteins. J. molec. Biol. 32, 343-358.
43. GILCHRIST, P. & BRADSHAW, J. (1993). Amyloid formation by salmon calcitonin. Biochim. Biophys. Acta 1182, 111-114.
44. GLENNER, G. G., EANES, E. D. & PAGE, D. L. (1972). The relation of the properties of congo red-stained amyloid fibrils to the β-conformation. J. Histochem. Cytochem. 20, 821-826.
45. GLENNER, G. G. (1980a). Amyloid deposits and amyloidosis - the β-fibrilloses 1. N. Eng. J. Med. 302, 1283-1292.
46. GLENNER, G. G. (1980b). Amyloid deposits and amyloidosis - the β-fibrilloses 2. N. Eng. J. Med. 302, 1333-1343.
47. GOREVIC, P., CASTANO, E., SARMA, R. & FRANGIONE, B. (1987). Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic X-ray diffraction pattern. Biochim. biophys. Res. Comm. 147, 854-862.
48. HAEZEBROUCK, P., JONIAU, M., VAN DAEL, H., HOOKE, S. D., WOODRUFF, N. & DOBSON, C. M. (1995). An equilibrium partially folded state of human lysozyme at low pH. J. molec. Biol. 246, 382-387.
49. HAMILTON, J. A., STEINRAUF, L. K., LIEPNIEKS, J., BENSON, M. D., HOLMGREN, G., SANDGREN, O. & STEEN, L. (1992). Alteration of molecular structure which results in disease; the Met30 variant of human plasma transthyretin. Biochim. biophys. Acta 1139, 9-13.
50. HAMILTON, J., STEINRAUF, L., BRADEN, B., LIEPNIEKS, J., BENSON, M., HOLMGREN, G., SANDGREN, O. & STEEN, L. (1993). The X-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-Met variant to 1.7 Å resolution. J. biol. Chem. 268, 2416-2424.
51. HARRISON, P. M., BAMBOROUGH, P., DAGGETT, V., PRUSINER, S. B. & COHEN, F. E. (1997). The prion folding problem. Curr. Opin. Struct. Biol. 7, 53-59.
52. HELMS, L. R. & WETZEL, R. (1996). Specificity of abnormal assembly in immunoglobulin light-chain deposition disease and amyloidosis. J. molec. Biol. 257, 77-86.
53. HILBICH, C., KISTERS-WOIKE, B., REED, J., MASTERS, C. & BEYREUTHER, K. (1991). Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. molec. Biol. 218, 149-163.
54. HOOKE, S. D., RADFORD, S. E. & DOBSON, C. M. (1994). The refolding of human lysozyme: a comparison with the structurally homologous hen lysozyme. Biochemistry 33, 5867-5876.
55. HURLE, M. R., HELMS, L. R., LI, L., CHAN, W. & WETZEL, R. (1994). A role for destabilizing amino acid replacements in light chain amyloidosis. Proc. natn. Acad. Sci. USA 91, 5446-5450.
56. INOUYE, H., FRASER, P.E. & KIRSCHNER, D. A. (1993). Structure of β-crystallite assemblies formed from Alzheimer β-amyloid protein analogues: analysis by X-ray diffraction. Biophys. J. 64, 502-519.
57. INOUYE, H. & KIRSCHNER, D. A. (1997). X-Ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative α-helices. J. molec. Biol. 268, 375-389.
58. KANEKO, K., ZULIANELLO, L., SCOTT, M., COOPER, C. M., WALLACE, A. C., JAMES, T. L., COHEN, F. E. & PRUSINER, S. B. (1997). Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. natn. Acad. Sci. USA 94, 10069-10074.
59. KELLY, J. W. & LANSBURY, P. T. (1994). A chemical approach to elucidate the mechanism of transthryretin and β-protein amyloid fibril formation. Amyloid : Int. J. exp. clin. Invest. 1, 186-205.
60. KELLY, J. W. (1996). Alternative conformations of amyloidogenic proteins govern their behaviour. Curr. Opin. Struct. Biol. 6, 11-17.
61. KELLY, J. W. (1997). Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion disease. Structure 5, 595-600.
62. KIRSCHNER, D. A., ABRAHAM, C. & SELKOE, D. A. (1986). X-Ray diffraction from intraneuronal paired helical filaments and extra-neuronal amyloid fibres in Alzheimer's disease indicates cross-β conformation. Proc. natn. Acad. Sci. USA 83, 503-507.
63. KIRSCHNER, D. A., INOUYE, H., DUFFY, L., SINCLAIR, A., LIND, M. & SELKOE, D. A. (1987). Synthetic peptide homologous to β-protein from Alzheimer's disease forms amyloid-like fibrils in vitro. Proc. natn. Acad. Sci. USA 84, 6953-6957.
64. KRAULIS, P. J. (1991). Molscript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
65. LEVITT, M. & CHOTHIA, C. (1976). Structural patterns in globular proteins. Nature 261, 552-558.
66. MCCUTCHEN, S. & KELLY, J. W. (1993). Intermolecular disulphide linkages are not required for transthyretin amyloid fibril formation in vitro. Biochem. biophys. Res. Commun. 197, 415-421.
67. MCCUTCHEN, S. L., LAI, Z., MIROY, G. J., KELLY, J. W. & COLON, W. (1995). Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease. Biochemistry 34, 13527-13536.
68. MCCUTCHEN, S., COLON, W. & KELLY, J. W. (1993). Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 32, 12119-12127.
69. MERRITT, E. A. & MURPHY, M. E. P. (1994). Raster3d version 2.0 - a program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869-873.
70. MINOR, D. L. JR. & KIM, P. S. (1996). Context-dependent secondary structure formation of a designed protein sequence. Nature 380, 730-734.
71. MISSMAHL, H. P. & HARTWIG, M. (1953). Polarisationsoptische Untersuchungen an der Amyloidsubstanz. Virchows Arch. Path. Anat. 324, 489-508.
72. NGUYEN, J. T., INOUYE, H., BALDWIN, M. A., FLETTERICK, R., COHEN, F. E., PRUSINER, S. B. & KIRSCHNER, D. A. (1995). X-Ray diffraction from scrapie prion rod and PrP peptides. J. molec. Biol. 252, 412-422.
73. NOLTE, R. T. & ATKINSON, D. (1992). Conformational analysis of apolipoprotein A-1 and E-3 based on primary sequence and circular dichroism. Biophys. J. 63, 1221-1239.
74. PAN, K.-M., BALDWIN, M. A., NGUYEN, J. T., GASEET, M., SERBAN, A., GROTH, D., MEHLHORN, I., HUANG, Z., FLETTERICK, R. J., COHEN, F. E. & PRUSINER, S. B. (1993). Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. natn. Acad. Sci. USA 90, 10962-10966.
75. PAULING, L. & COREY, R. (1951). Configuration of polypeptide chains with favoured orientation around single bonds: two new pleated sheets. Proc. natn. Acad. Sci. USA 37, 729-739.
76. PEPYS, M. B., HAWKINS, P. N., BOOTH, D. R., VIGUSHIN, D. M., TENNENT, G. A., SOUTAR, A. K., TOTTY, N., NGUYEN, O., BLAKE, C. C. F., TERRY, C. J., FEEST, T. G., ZALIN, A. M. & HSUAN, J. J. (1993). Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362, 553-557.
77. PEPYS, M. B. (1994). 'Amyloidosis'. In Samter's Immunologic Diseases (ed. M. M. Frank, K. F. Austen, H. N. Claman & E. R. Unanue), pp. 637-655. Boston: Little, Brown & Co.
78. PERUTZ, M. F. (1997). Amyloid fibrils: mutations make enzyme polymerize. Nature 385, 773-775.
79. PRUSINER, S. B. (1996). Molecular biology and pathogenesis of prion diseases. Trends Biochem. Sci. 21, 482-487.
80. RADFORD, S. E., DOBSON, C. M. & EVANS, P. A. (1992). The folding of hen lysozyme involves partially structured intermediates and multiple pathways. Nature 358, 302-307.
81. 1H NMR Studies of human lysozyme: spectral assignment and comparison with hen lysozyme. Biochemistry 29, 7201-7214.
82. REEKE, G. N., HARTSUCK, J. A., LUDWIG, M. L., QUIOCHO, F. A., STEITZ, T. A. & LIPSCOMB, W. N. (1967). The structure of carboxypeptidase A, VI. Some results at 2.0 Å resolution and the complex with glycyl-tyrosine at 2.8 Å resolution. Proc. natn. Acad. Sci. USA 58, 2220-2226.
83. RICHARDSON, J. (1981). The anatomy and taxonomy of protein structure. Adv. Prot. Chem. 34, 167-339.
84. RIEK, R., HORNEMANN, S., WIDER, G., BILLETER, M., GLOCKSHUBER, R. & WÜTHRICH, K. (1996). NMR structure of the mouse prion protein domain PrP(121-231). Nature 382, 180-182.
85. SAFAR, J., ROLLER, P., GAJDUSEK, D. & GIBBS, C. (1994). Scrapie amyloid (prion) has the conformational characteristics of an aggregated molten globular folding intermediate. Biochemistry 33, 8375-8383.
86. SANDGREN, O., HOLMGREN, G. & LUNDGREN, E. (1990). Vitreous amyloidosis associated with homozygosity for the transthyretin methionine-30 gene. Arch. Ophthalmol. 108, 1584-1588.
87. SARAIVA, M. J. M. (1995). Transthyretin mutations in health and disease. Human Mutation 5, 191-196.
88. SARAIVA, M. J. M., ALMEIDA, M. R., ALVES, I. L., BONIFACIO, M. J., DAMAS, A. M., PALHA, J. A. GOLDSTEINS, G. & LUNDGREN, E. (1996). Modulating conformational factors in transthyretin amyloid. In CIBA Symposium No. 199 The Nature and Origin of Amyloid Fibrils, pp. 47-58. Chichester, U.K.: John Wiley and Sons Ltd.
89. SCHERZINGER, E., LURZ, R., TURMAINE, M., MANGIARINI, L., HOLLENBACH, B., HASENBANK, R, BATES, G. P., DAVIES, S. W., LEHRACH, H. & WANKER, E. E. (1997). Huntington-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558.
90. SCHORMANN, N., MURRELL, J. R., LIEPNIEKS, J. & BENSON, M. (1995). Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model tor amyloid fibril formation. Proc. natn. Acad. Sci. USA 92, 9490-9494.
91. SEBASTIAO, P., DAUTER, Z., SARAIVA, M. J. M. & DAMAS, A. M. (1996). Crystallization and preliminary X-ray diffraction studies of Leu55Pro variant of transthyretin. Acta Crystallogr. D 52, 566-568.
92. SERPELL, L. C. & BLAKE, C. C. F. (1994). Frequency analysis and structural correlation of FAP mutations in transthyretin. In Amyloid and Amyloidosis (ed. R. Kisilevsky, M. D. Benson, B. Frangione, J. Gauldie, T. J. Muckle and I. D. Youngs), pp. 447-450. New York: Parthenon Publishing Group Inc.
93. SERPELL, L. C., GOLDSTEINS, G., DACKLIN, I., LUNDGREN, E. & BLAKE, C. C. F. (1996). The 'edge strand' hypothesis: prediction and test of a mutational 'hot-spot' on the transthyretin molecule associated with FAP amyloidogenesis. Amyloid: Int. J. exp. clin. Invest. 3, 75-85.
94. SERPELL, L. C., SUNDE, M., FRASER, P. E., LUTHER, P. K., MORRIS, E., SANDGREN, O., LUNDGREN, E. & BLAKE, C. C. F. (1995). The examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. J. molec. Biol. 254, 113-118.
95. SERPELL, L. C. (1996). Structural studies of amyloid proteins. D.Phil. Thesis, University of Oxford.
96. SHIRAHAMA, T. & COHEN, A. S. (1967). High resolution electron microscopic analysis of the amyloid fibril. J. Cell. Biol. 33, 679-706.
97. SOTO, C., CASTANO, E., FRANGIONE, B. & INESTROSA, N. (1995). The α-helical to β-sheet transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. biol. Chem. 270, 3063-3067.
98. STEINRAUF, L. K., HAMILTON, J. A., BRADEN, B. C., MURRELL, J. R. & BENSON, M. D. (1993). X-Ray crystal structure of the Ala109Thr variant of human transthyretin which produces euthyroid hyperthyroxinemia. J. biol. Chem. 268, 2425-2430.
99. SUNDE, M., SERPELL, L. C., BARTLAM, M., PEPYS, M. B., FRASER, P. E. & BLAKE, C. C. F. (1997). The common core structure of amyloid fibrils by synchrotron X-ray diffraction, J. molec. Biol. 273, 729-739.
100. TAGLIAVINI, F., PRELLI, F., VERGA, L., GIACCONE, G., JARMA, R., GOREVIC, P., GHETTI, B., PASSERENI, F., GHIBAUDI, E., FORLONI, G., SALMONA, M., BUGANI, O. & FRANGIONE, B. (1993). Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc. natn. Acad. Sci. USA 90, 9678-9682.
101. TELLING, G. C., SCOTT, M., MASTRAINNI, J., GABIZON, R. TORCHIA, M., COHEN, F. E., DEARMOND, S. J. & PRUSINER, S. B. (1995). Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90.
102. TELLING, G. C., PARCHI, P., DEARMOND, S. J., CORTELLI, P., MONTAGNA, P., GABIZON, R., MASTRIANNI, J., LUGARESI, E., GAMBETTI, P. & PRUSINER, S. B. (1996). Evidence for the conformation of the pathological isoform of the prion protein enciphering and propagating prion diversity. Science 274, 2079-2082.
103. TERMINE, J. D., EANES, E. D., EIN, D. & GLENNER, G. G. (1972). Infrared spectroscopy of human amyloid fibrils and immunoglobulin proteins. Biopolymers 11, 1103-1113.
104. TERRY, C. J., DAMAS, A. M., OLIVIERA, P., SARAIVA, M. J. M., ALVES, A. L., COSTA, P. P., MATIAS, P. M., SAKAKI, Y. & BLAKE, C. C. F. (1993). Structure of Met30 variant of transthyretin and its amyloidogenic variations. EMBO Journal 12, 735-741.
105. THYLEN, C., WAHLCHRIST, J., HAETNER, E., SANDGREN, O., HOLMGREN, G. & LUNDGREN, E. (1993). Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO Journal 12, 743-748.
106. 1, presumptive identification of calcium and lipid binding sites. Mol. Biol. Med. 3, 387-407.
107. TURNELL, W., SAKA, R., BAUM, J., CASPI, D., BATTZ, M. & PEPYS, M. B. (1986b). X-ray scattering and diffraction by wet gels of AA amyloid. Mol. Biol. Med. 3, 409-424.
108. VIDAL, R., GARZULY, F., BUDKA, H., LALOWSKI, M., LINKE, R. P., FRANGIONE, B. & WIESNIEWSKI, T. (1996). Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon-18. Am. J. Path. 148, 361-366.
109. VIRCHOW, R. (1854). Zur Celluslose-Frage. Virchows Arch. 6, 415-426.
110. WESTERMARK, P., SLETTEN, K., JOHAMSON, B. & CORNWELL, G. (1990). Fibril in senile systemic amyloid is derived from normal transthyretin. Proc. natn. Acad. Sci. USA, 87, 2843-2845.
111. WETZEL, R. (1996). For protein misassembly, its the I decade. Cell 86, 699-702.
112. WETZEL, R. (1994). Mutations and off-pathway aggregation of proteins. Trends Biotechnol. 12, 193-198.
113. WILLE, H., ZHANG, G.-F., BALDWIN, M. A., COHEN, F. E. & PRUSINER, S. B. (1996). Separation of scrapie prion infectivity from PrP amyloid polymers. J. molec. Biol. 259, 608-621.
114. WOOD, S. J., MALEEF, B., HART, T. & WETZEL, R. (1996). Physical, morphological and functional differences between pH 5.9 and 7.4 aggregates of the Alzheimer's peptide Aβ. J. molec. Biol. 256, 870-877.
115. ZHANG, H., STÖCKEL, J., MELHORN, I., GROTH, D., BALDWIN, M. A., PRUSINER, S. B., JAMES, T. L. & COHEN, F. E. (1997). Physical studies of conformational plasticity in a recombinant prion protein. Biochemistry 36, 3543-3553.